ECG Patch Added to the Caretaker® Wireless Patient Monitoring Platform

Reports o the Caretaker® Wireless Continuous Blood Pressure & Patient Monitoring Platform

Caretaker Medical provides clinical-grade wireless patient monitoring and is the maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Cuff to measure Real-time “Beat by Beat” Continuous Blood Pressure, Respiration Rate, and other hemodynamic parameters, has incorporated VivaLNK’s FDA-Cleared ECG Patch to their wireless patient monitoring platform.

The Caretaker® patient monitor provides clinicians with continuous, uninterrupted Blood Pressure and Vital Signs data across the full continuum of care in a completely wire-free form factor that maximizes patient mobility and provides a comprehensive view of hemodynamic health.  Clinicians can remotely view patient data from virtually anywhere using the Caretaker App, the CaretakerCloud Remote Monitoring Portal, or via data integration with other monitoring platforms.

“Our patented Pulse Decomposition Analysis method of non-invasive hemodynamic measurements like continuous beat-by-beat Blood Pressure provides clinicians with a view of the patient’s mechanical heart function, and VivaLNK’s reusable ECG Patch reveals the status of the patient’s electrical heart function,” said Jeff Pompeo, Caretaker Medical’s President & CEO.  “Combined, the Caretaker monitoring platform now provides a seamless view of both electrical and mechanical heart health, including waveforms, in a completely wire-free, wearable form factor that doesn’t inhibit patient mobility.”

Both the Caretaker wireless monitor and the VivaLNK ECG Patch are FDA-Cleared and CE-Mark certified and available for purchase from Caretaker Medical and its distributors.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”